Currently, there are 503.47M common shares owned by the public and among those 384.18M shares have been available to trade.
The company’s stock has a 5-day price change of -6.37% and -25.33% over the past three months. LILM shares are trading -38.56% year to date (YTD), with the 12-month market performance up to 12.28% higher. It has a 12-month low price of $0.60 and touched a high of $1.41 over the same period. LILM has an average intraday trading volume of 3.32 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.26%, -3.84%, and -18.05% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Lilium N.V (NASDAQ: LILM) shares accounts for 4.42% of the company’s 503.47M shares outstanding.
It has a market capitalization of $451.09M and a beta (3y monthly) value of 1.88. The earnings-per-share (ttm) stands at -$0.16. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.94% over the week and 7.60% over the month.
Earnings per share for the fiscal year are expected to increase by 13.05%, and 8.19% over the next financial year.
Looking at the support for the LILM, a number of firms have released research notes about the stock. Cantor Fitzgerald stated their Overweight rating for the stock in a research note on July 19, 2024, with the firm’s price target at $2. B. Riley Securities coverage for the Lilium N.V (LILM) stock in a research note released on August 01, 2023 offered a Buy rating with a price target of $3. Canaccord Genuity was of a view on July 17, 2023 that the stock is Buy, while Canaccord Genuity gave the stock Buy rating on July 14, 2023, issuing a price target of $1.20- $3. Canaccord Genuity on their part issued Hold rating on June 09, 2023.
